Trials / Conditions / Carcinoma, Thymic
Carcinoma, Thymic
5 registered clinical trials studyying Carcinoma, Thymic.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs NCT04985357 | Travera Inc | — |
| Active Not Recruiting | A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advance NCT05544929 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) NCT05461430 | Travera Inc | — |
| Completed | A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With NCT04321330 | Hoffmann-La Roche | Phase 2 |
| Completed | Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and NCT01306045 | National Cancer Institute (NCI) | Phase 2 |